These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 16221060)

  • 1. Treatment of childhood acute myeloid leukemia.
    ter Bals E; Kaspers GJ
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
    Kaspers GJ; Zwaan CM
    Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep.
    Woods WG
    Pediatr Blood Cancer; 2006 May; 46(5):565-9. PubMed ID: 16261562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
    Mandelli F; Petti MC; Lo Coco F
    Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Consolidation of therapy of acute myeloid leukemia with the AML-BFM 93 protocol in children in the Czech Republic].
    Starý J; Gajdos P; Blazek B; Ptoszková H; Hrstková H; Kopecná L; Tousovská K; Hak J; Procházková D; Cerná Z; Jabali Y; Timr P; Vávra V; Sedlácek P; Smísek P; Hrusák O; Michalová K
    Cas Lek Cesk; 2004; 143(4):257-63. PubMed ID: 15218726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia.
    Rubnitz JE; Gibson B; Smith FO
    Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostics and therapy of acute myeloid leukemia].
    Fritsch S; Metzeler K; Hiddemann W; Buske C
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
    Meshinchi S; Arceci RJ
    Oncologist; 2007 Mar; 12(3):341-55. PubMed ID: 17405900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
    Stanulla M; Cario G; Meissner B; Schrauder A; Möricke A; Riehm H; Schrappe M
    Blood Cells Mol Dis; 2007; 39(2):160-3. PubMed ID: 17532236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute myeloid leukemia in older patients.
    Roboz GJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now.
    Goulden N; Virgo P; Grimwade D
    Br J Haematol; 2006 Aug; 134(3):273-82. PubMed ID: 16848770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A
    J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloid leukemia].
    Tabuchi K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):156-61. PubMed ID: 17301520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myeloid leukemia in the elderly: a review].
    Thomas X; Belhabri A
    Bull Cancer; 2001 Feb; 88(2):143-54. PubMed ID: 11257589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.
    Zwaan CM; Kaspers GJ
    Br J Haematol; 2004 Nov; 127(3):264-79. PubMed ID: 15491285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment].
    Wedding U; Bokemeyer C; Meran JG; ; ;
    Med Klin (Munich); 2003 Apr; 98(4):193-207. PubMed ID: 12715143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.
    Gamis AS
    Pediatr Blood Cancer; 2005 Jan; 44(1):13-20. PubMed ID: 15534881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.